Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers

被引:28
作者
Bermeo-Cabrera, Janneth [1 ]
Almeda-Valdes, Paloma [1 ,2 ]
Riofrios-Palacios, Josefa [1 ]
Aguilar-Salinas, Carlos A. [1 ,2 ]
Mehta, Roopa [1 ,2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico
关键词
THERAPY; ATTITUDES;
D O I
10.1155/2018/3190849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate factors associated with insulin adherence in subjects with type 2 diabetes mellitus (T2D) attending a tertiary care centre in Mexico City. Material and Methods. Cross-sectional study, including 200 patients. Adherence to insulin therapy was measured with a medication adherence questionnaire. Sociodemographic data and factors related to insulin omission were collected and compared between the nonadherent and adherent groups. Results. We categorized 117 (58.5%) patients as nonadherent and 83 (41.5%) as adherent. Among the adherent, only 22 patients (11%) had excellent adherence to insulin therapy. The following factors were associated with nonadherence: lack of planning of daily activities (46.1%), fear of hypoglycemia (11%), economic factors (15.4%), and number of insulin applications (2.31 versus 1.76 applications per day). Conclusions. In this study, patients with type 2 diabetes attending a tertiary care referral centre showed inadequate adherence to insulin therapy. The principal factors associated with insulin omission were low socioeconomic status, fear of hypoglycemia, and a greater number of insulin applications per day.
引用
收藏
页数:7
相关论文
共 24 条
[2]  
[Anonymous], INT DIAB FED M
[3]  
[Anonymous], 2009, ASOCIACION LATINOAME
[4]   New forms of insulin and insulin therapies for the treatment of type 2 diabetes [J].
Cahn, Avivit ;
Miccoli, Roberto ;
Dardano, Angela ;
Del Prato, Stefano .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08) :638-652
[5]   Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review [J].
Davies, M. J. ;
Gagliardino, J. J. ;
Gray, L. J. ;
Khunti, K. ;
Mohan, V. ;
Hughes, R. .
DIABETIC MEDICINE, 2013, 30 (05) :512-524
[6]   Adherence to insulin treatment in diabetes: can it be improved? [J].
Doggrell, Sheila Anne ;
Chan, Vincent .
JOURNAL OF DIABETES, 2015, 7 (03) :315-321
[7]   Insulin adherence in patients with diabetes: Risk factors for injection omission [J].
Farsaei, Shadi ;
Radfar, Mania ;
Heydari, Zahra ;
Abbasi, Farzaneh ;
Qorbani, Mostafa .
PRIMARY CARE DIABETES, 2014, 8 (04) :338-345
[8]   CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2018 EXECUTIVE SUMMARY [J].
Garber, Alan J. ;
Abrahamson, Martin J. ;
Barzilay, Joshua I. ;
Blonde, Lawrence ;
Bloomgarden, Zachary T. ;
Bush, Michael A. ;
Dagogo-Jack, Samuel ;
DeFronzo, Ralph A. ;
Einhorn, Daniel ;
Fonseca, Vivian A. ;
Garber, Jeffrey R. ;
Garvey, W. Timothy ;
Grunberger, George ;
Handelsman, Yehuda ;
Hirsch, Irl B. ;
Jellinger, Paul S. ;
McGill, Janet B. ;
Mechanick, Jeffrey I. ;
Rosenblit, Paul D. ;
Umpierrez, Guillermo E. .
ENDOCRINE PRACTICE, 2018, 24 (01) :91-120
[9]   Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus [J].
Horvath, K. ;
Jeitler, K. ;
Berghold, A. ;
Ebrahim, S. H. ;
Gratzer, T. W. ;
Plank, J. ;
Kaiser, T. ;
Pieber, T. R. ;
Siebenhofer, A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02)
[10]  
Instituto Nacional de Salud Publica and Secretaria de Salud, 2018, ENC NAC SAL NUTR MED